Acute Effect of Intradialytic Aerobic Exercise on Hemodynamic Response, Dialysis-Related Side Effects and Proteome in Patients with Kidney Failure: A Pilot Study-Advances in Geriatric Medicine and Research-CSCIED科技核心评价数据库-手机版

Acute Effect of Intradialytic Aerobic Exercise on Hemodynamic Response, Dialysis-Related Side Effects and Proteome in Patients with Kidney Failure: A Pilot Study

Acute Effect of Intradialytic Aerobic Exercise on Hemodynamic Response, Dialysis-Related Side Effects and Proteome in Patients with Kidney Failure: A Pilot Study

ES评分 0 浏览量：234 下载量：0

全文阅读下载引用收藏

DOI	10.20900/agmr20240006
刊名	Advances in Geriatric Medicine and Research AGMR
年，卷(期)	2024, 6(4)
作者	Laurence Poirier,Alexis Marcotte-Chénard,Renaud Tremblay,Lara Deslauriers,Mélanie Godin,Dominique Lévesque,François-Michel Boisvert,Eléonor Riesco*,
作者单位	Faculty of Physical Activity Sciences, University of Sherbrooke, Sherbrooke, QC J1K 2R1, Canada ; Hemodialysis Service, CIUSSS de l’Estrie—CHUS, Sherbrooke, QC J1H 5N4, Canada ; Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1E 4K8, Canada ;
摘要	Background/Objectives: Hemodialysis (HD) is the renal replacement therapy with the most adverse side effects, including variations in blood pressure (BP). Intradialytic exercise (IDE) seems to be the non-pharmacological approach of choice for managing treatment-induced symptoms. The objectives were (1) to evaluate the effect of acute IDE on hemodynamic response (BP) and short-term treatment-associated symptoms in patients with kidney failure and (2) to test the feasibility to quantify the proteome of these patients in response to IDE and establish its relationship with BP variations during HD. Methods: Ten adults undergoing HD completed a randomized crossover study with two experimental conditions (HD; HD with IDE). BP was measured before and after HD, and at five time points following conditions. Symptom burden was assessed 24 h and 7 days after each condition. Blood samples were collected for proteomics analysis at the end of conditions. Results: IDE downregulated BP during HD without adverse events and decreased the desire to sleep in the 2 hours following HD. Proteomics analysis revealed that five proteins were downregulated and seven upregulated in response to IDE, although it was not associated with BP variation. Conclusion and Implications: A single session of moderate-intensity IDE seems sufficient to improve BP control and to reduce the desire to sleep after treatment without any adverse effects. This study also demonstrates that it is feasible to quantify the proteome in individuals with kidney failure, which could lead to the development of precision interventions in exercise to improve the quality of care for deconditioned, multimorbid individuals.
Abstract	Background/Objectives: Hemodialysis (HD) is the renal replacement therapy with the most adverse side effects, including variations in blood pressure (BP). Intradialytic exercise (IDE) seems to be the non-pharmacological approach of choice for managing treatment-induced symptoms. The objectives were (1) to evaluate the effect of acute IDE on hemodynamic response (BP) and short-term treatment-associated symptoms in patients with kidney failure and (2) to test the feasibility to quantify the proteome of these patients in response to IDE and establish its relationship with BP variations during HD. Methods: Ten adults undergoing HD completed a randomized crossover study with two experimental conditions (HD; HD with IDE). BP was measured before and after HD, and at five time points following conditions. Symptom burden was assessed 24 h and 7 days after each condition. Blood samples were collected for proteomics analysis at the end of conditions. Results: IDE downregulated BP during HD without adverse events and decreased the desire to sleep in the 2 hours following HD. Proteomics analysis revealed that five proteins were downregulated and seven upregulated in response to IDE, although it was not associated with BP variation. Conclusion and Implications: A single session of moderate-intensity IDE seems sufficient to improve BP control and to reduce the desire to sleep after treatment without any adverse effects. This study also demonstrates that it is feasible to quantify the proteome in individuals with kidney failure, which could lead to the development of precision interventions in exercise to improve the quality of care for deconditioned, multimorbid individuals.
关键词	hemodialysis; intradialytic cycling; therapeutic targets; blood pressure; proteomics; treatment-related symptoms
KeyWord	hemodialysis; intradialytic cycling; therapeutic targets; blood pressure; proteomics; treatment-related symptoms
基金项目
页码	-

参考文献
相关文献

1.CIHI. Incidence of End-Stage Kidney Disease (ESKD), by Primary Diagnosis from 2012 to 2021. Toronto (Canada): Canadian Institute for Health Information (CIHI), 2020.

2.Elshahat S, Cockwell P, Maxwell AP, Griffin M, O’Brien T, O’Neill C. The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review. PLoS One. 2020;15(3):e0230512.

3.Fraser S, Blakeman T. Chronic kidney disease: identification and management in primary care. Pragmat Obs Res. 2016;7:21-32.

4.Hirst JA, Ordóñez Mena JM, O’Callaghan CA, Ogburn E, Taylor CJ, Yang Y, et al. Prevalence and factors associated with multimorbidity among primary care patients with decreased renal function. PLoS One. 2021;16(1):e0245131.

5.Almutary H, Bonner A, Douglas C. Symptom burden in chronic kidney disease: a review of recent literature. J Renal Care. 2013;39(3):140-50.

6.Yildiz AB, Vehbi S, Covic A, Burlacu A, Covic A, Kanbay M. An update review on hemodynamic instability in renal replacement therapy patients. Int Urol Nephrol. 2023;55(4):929-42.

7.Stefansson BV, Brunelli SM, Cabrera C, Rosenbaum D, Anum E, Ramakrishnan K, et al. Intradialytic hypotension and risk of cardiovascular disease. Clin J Am Soc Nephrol. 2014;9(12):2124-32.

8.Kanbay M, Ertuglu LA, Afsar B, Ozdogan E, Siriopol D, Covic A, et al. An update review of intradialytic hypotension: concept, risk factors, clinical implications and management. Clin Kidney J. 2020;13(6):981-93.

9.Barbieri M, Chiodini P, Di Gennaro P, Hafez G, Liabeuf S, Malyszko J, et al. Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review. Pharmacol Res. 2024;203:107146.

10.Kuipers J, Oosterhuis JK, Paans W, Krijnen WP, Gaillard CAJM, Westerhuis R, et al. Association between quality of life and various aspects of intradialytic hypotension including patient-reported intradialytic symptom score. BMC Nephrol. 2019;20(1):1-8.

11.Meredith DJ, Pugh CW, Sutherland S, Tarassenko L, Birks J. The relationship between symptoms and blood pressure during maintenance hemodialysis. Hemodial Int. 2015;19(4):543-52.

12.Tian Z, Liang M. Renal metabolism and hypertension. Nat Commun. 2021;12(1):963.

13.Daugirdas JT. Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis. 2001;38(4):S11-7.

14.Hirakata H, Nitta K, Inaba M, Shoji T, Fujii H, Kobayashi S, et al. Japanese Society for Dialysis Therapy Guidelines for Management of Cardiovascular Diseases in Patients on Chronic Hemodialysis. Ther Apher Dial. 2012;16(5):387-435.

15.Assayag M, Levy D, Seris P, Maheas C, Langlois AL, Moubakir K, et al. Relative Change of Protidemia Level Predicts Intradialytic Hypotension. J Am Heart Assoc. 2020;9(1):e014264.

16.Davison SN, Jhangri GS. Impact of Pain and Symptom Burden on the Health-Related Quality of Life of Hemodialysis Patients. J Pain Symptom Manag. 2010;39(3):477-85.

17.Ng MSN, Miaskowski C, Cooper B, Hui YH, Ho EHS, Mo SKL, et al. Distinct Symptom Experience Among Subgroups of Patients With ESRD Receiving Maintenance Dialysis. J Pain Symptom Manag. 2020;60(1):70-9.

18.Abdel-Kader K, Unruh ML, Weisbord SD. Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clin J Am Soc Nephrol. 2009;4(6):1057-64.

19.Ekman I, Swedberg K, Taft C, Lindseth A, Norberg A, Brink E, et al. Person-centered care—ready for prime time. Eur J Cardiovasc Nurs. 2011;10(4):248-51.

20.Lange E, Palstam A, Gjertsson I, Mannerkorpi K. Aspects of exercise with person-centred guidance influencing the transition to independent exercise: a qualitative interview study among older adults with rheumatoid arthritis. Eur Rev Aging Phys A. 2019;16(1):1-12.

21.Keller S, Dy S, Wilson R, Dukhanin V, Snyder C, Wu A. Selecting Patient-Reported Outcome Measures to Contribute to Primary Care Performance Measurement: a Mixed Methods Approach. J Gen Intern Med. 2020;35(9):2687-97.

22.Bohm C, Schick‐Makaroff K, Macrae JM, Tan M, Thompson S. The role of exercise in improving patient‐reported outcomes in individuals on dialysis: A scoping review. Semin Dialysis. 2019;32(4):336-50.

23.Kercher VMM, KercherK, Levy P, Bennion T, Alexander C, Amaral PC, et al. 2023 Fitness Trends from Around the Globe. Health Fit J. 2023;27(1):19-30.

24.Araujo AM, Orcy RB, Feter N, Weymar MK, Cardoso RK, Bohlke M, et al. Effects of intradialytic exercise on functional capacity in patients with end-stage chronic kidney disease: a systematic review and meta-analysis. Res Sports Med. 2024;32(1):28-48.

25.Hu H, Liu X, Chau PH, Choi EPH. Effects of intradialytic exercise on health-related quality of life in patients undergoing maintenance haemodialysis: a systematic review and meta-analysis. Qual Life Res. 2022;31(7):1915-32.

26.Intiso D. The Rehabilitation Role in Chronic Kidney and End Stage Renal Disease. Kidney Blood Press Res. 2014;39(2–3):180-8.

27.Melendez Oliva E, Villafane JH, Alonso Perez JL, Alonso Sal A, Molinero Carlier G, Quevedo Garcia A, et al. Effect of Exercise on Inflammation in Hemodialysis Patients: A Systematic Review. J Pers Med. 2022;12(7):1188.

28.Pu J, Jiang Z, Wu W, Li L, Zhang L, Li Y, et al. Efficacy and safety of intradialytic exercise in haemodialysis patients: a systematic review and meta-analysis. BMJ Open. 2019;9(1):e020633.

29.Kim JS, Yi JH, Shin J, Kim YS, Han SW. Effect of acute intradialytic aerobic and resistance exercise on one-day blood pressure in patients undergoing hemodialysis: a pilot study. J Sports Med Phys Fitness. 2019;59(8):1413-9.

30.McGuire S, Horton EJ, Renshaw D, Jimenez A, Krishnan N, McGregor G. Hemodynamic Instability during Dialysis: The Potential Role of Intradialytic Exercise. Biomed Res Int. 2018;2018:8276912.

31.Neufer PD, Bamman MM, Muoio DM, Bouchard C, Cooper DM, Goodpaster BH, et al. Understanding the Cellular and Molecular Mechanisms of Physical Activity-Induced Health Benefits. Cell Metab. 2015;22(1):4-11.

32.Sanford JA, Nogiec CD, Lindholm ME, Adkins JN, Amar D, Dasari S, et al. Molecular Transducers of Physical Activity Consortium (MoTrPAC): Mapping the Dynamic Responses to Exercise. Cell. 2020;181(7):1464-74.

33.Flythe JE, Hilliard T, Castillo G, Ikeler K, Orazi J, Abdel-Rahman E, et al. Symptom Prioritization among Adults Receiving In-Center Hemodialysis: A Mixed Methods Study. Clin J Am Soc Nephrol. 2018;13(5):735-45.

34.KD W. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45:S1-153.

35.Han S, Yang K, Zhu H, Liu J, Zhang L, Zhao J. Proteomics investigation of the changes in serum proteins after high- and low-flux hemodialysis. Ren Fail. 2018;40(1):506-13.

36.Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137-47.

37.Ferguson B. ACSM’s Guidelines for Exercise Testing and Prescription (9th ed). J Can Chiropr Assoc. 2014;58(3):328.

38.Lambert K, Lightfoot CJ, Jegatheesan DK, Gabrys I, Bennett PN. Physical activity and exercise recommendations for people receiving dialysis: A scoping review. PLoS One. 2022;17(4):e0267290.

39.Liguori G. ACSM’s guidelines for exercise testing and prescription. 11th ed. Philadelphia (US): LWW; 2021.

40.Coletta AM, Agha NH, Baker FL, Niemiro GM, Mylabathula PL, Brewster AM, et al. The impact of high-intensity interval exercise training on NK-cell function and circulating myokines for breast cancer prevention among women at high risk for breast cancer. Breast Cancer Res Treat. 2021;187(2):407-16.

41.Carreira MA, Nogueira AB, Pena FM, Kiuchi MG, Rodrigues RC, Rodrigues RR, et al. Detection of autonomic dysfunction in hemodialysis patients using the exercise treadmill test: the role of the chronotropic index, heart rate recovery, and R-R variability. PLoS One. 2015;10(6):e0128123.

42.Celik A, Melek M, Yuksel S, Onrat E, Avsar A. Cardiac autonomic dysfunction in hemodialysis patients: The value of heart rate turbulence. Hemodial Int. 2011;15(2):193-9.

43.Bonello M, House AA, Cruz D, Asuman Y, Andrikos E, Petras D, et al. Integration of blood volume, blood pressure, heart rate and bioimpedance monitoring for the achievement of optimal dry body weight during chronic hemodialysis. Int J Artif Organs. 2007;30(12):1098-108.

44.Lai S, Bagordo D, Perrotta AM, Gigante A, Gasperini ML, Muscaritoli M, et al. Autonomic dysfunction in kidney diseases. Eur Rev Med Pharmacol Sci. 2020;24(16):8458-68.

45.Thapa L, Karki P, Sharma SK, Bajaj BK. Cardiovascular autonomic neuropathy in chronic kidney diseases. J Nepal Med Assoc. 2010;49(178):121-8.

46.Parent-Roberge H, Deshayes TA, Fortier C, Marquis K, Lacharite-Lemieux C, Rodrigue C, et al. Feasibility of an Intradialytic Combined Exercise Program Targeting Older Adults With End-Stage Renal Disease. J Aging Phys Act. 2021;29(6):905-14.

47.Chou JA, Streja E, Nguyen DV, Rhee CM, Obi Y, Inrig JK, et al. Intradialytic hypotension, blood pressure changes and mortality risk in incident hemodialysis patients. Nephrol Dial Transplant. 2018;33(1):149-59.

48.Singh AT, Waikar SS, Mc Causland FR. Association of Different Definitions of Intradialytic Hypertension With Long-Term Mortality in Hemodialysis. Hypertension. 2022;79(4):855-62.

49.Moskowitz DS, Young SN. Ecological momentary assessment: what it is and why it is a method of the future in clinical psychopharmacology. J Psychiatry Neurosci. 2006;31(1):13-20.

50.Kalantar-Zadeh K, Lockwood MB, Rhee CM, Tantisattamo E, Andreoli S, Balducci A, et al. Patient-centred approaches for the management of unpleasant symptoms in kidney disease. Nat Rev Nephrol. 2022;18(3):185-98.

51.van der Willik EM, Hemmelder MH, Bart HAJ, van Ittersum FJ, Hoogendijk-van den Akker JM, Bos WJW, et al. Routinely measuring symptom burden and health-related quality of life in dialysis patients: first results from the Dutch registry of patient-reported outcome measures. Clin Kidney J. 2021;14(6):1535-44.

52.Weisbord SD, Fried LF, Arnold RM, Rotondi AJ, Fine MJ, Levenson DJ, et al. Development of a symptom assessment instrument for chronic hemodialysis patients: the Dialysis Symptom Index. J Pain Symptom Manag. 2004;27(3):226-40.

53.Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994;3(5):329-38.

54.Dauphinee SW, Gauthier L, Gandek B, Magnan L, Pierre U. Readying a US measure of health status, the SF-36, for use in Canada. Clin Invest Med. 1997;20(4):224-38

55.Washburn RA, McAuley E, Katula J, Mihalko SL, Boileau RA. The physical activity scale for the elderly (PASE): evidence for validity. J Clin Epidemiol. 1999;52(7):643-51.

56.Washburn RA, Smith KW, Jette AM, Janney CA. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol. 1993;46(2):153-62.

57.Liu M, Legault V, Fulop T, Cote AM, Gravel D, Blanchet FG, et al. Prediction of Mortality in Hemodialysis Patients Using Moving Multivariate Distance. Front Physiol. 2021;12:612494.

58.Lewis M, Bromley K, Sutton CJ, McCray G, Myers HL, Lancaster GA. Determining sample size for progression criteria for pragmatic pilot RCTs: the hypothesis test strikes back! Pilot Feasibility Stud. 2021;7(1):40.

59.Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale (US): Lawrance Erlbaum Associates; 1988.

60.Rosenthal R. Parametric Measures of Effect Size. In: Cooper H, Hedges LV, editors. The Handbook of Research Synthesis. New York (US): Russell Sage Foundation; 1994. p. 231-44.

61.Curran-Everett D. Multiple comparisons: philosophies and illustrations. Am J Physiol Regul Integr Comp Physiol. 2000;279(1):R1-8.

62.Chauvin A, Wang CS, Geha S, Garde-Granger P, Mathieu AA, Lacasse V, et al. The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature. Clin Proteomics. 2018;15:1-16.

63.Wasserstein RL, Schirm AL, Lazar NA. Moving to a World Beyond “p < 0.05”. Am Stat. 2019;73(sup1):1-19.

64.Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334-57.

65.Punzi HA. Why ambulatory blood pressure monitoring? Am J Health Syst Pharm. 1998;55(Suppl 3):S12-6.

66.Rossum K, Hancock E, Thompson S, Brar R, Riehl-Tonn V, Garcia E, et al. A Randomized Trial Examining the Impact of Timing of Intradialytic Cycling on Intradialytic Hypotension. Kidney Int Rep. 2023;8(5):1002-12.

67.Gonzalez-Chavez SA, Quinonez-Flores CM, Espino-Solis GP, Vazquez-Contreras JA, Pacheco-Tena C. Exercise Exacerbates the Transcriptional Profile of Hypoxia, Oxidative Stress and Inflammation in Rats with Adjuvant-Induced Arthritis. Cells. 2019;8(12):1493.

68.Ye S, Huang Y, Joshi S, Zhang J, Yang F, Zhang G, et al. Platelet secretion and hemostasis require syntaxin-binding protein STXBP5. J Clin Invest. 2014;124(10):4517-28.

69.Zhu Q, Yamakuchi M, Ture S, de la Luz Garcia-Hernandez M, Ko KA, Modjeski KL, et al. Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion. J Clin Invest. 2014;124(10):4503-16.

70.Lowenstein CJ, Morrell CN, Yamakuchi M. Regulation of Weibel-Palade body exocytosis. Trends Cardiovasc Med. 2005;15(8):302-8.

71.Schillemans M, Karampini E, Kat M, Bierings R. Exocytosis of Weibel-Palade bodies: how to unpack a vascular emergency kit. J Thromb Haemost. 2019;17(1):6-18.

72.Koseoglu S, Flaumenhaft R. Advances in platelet granule biology. Curr Opin Hematol. 2013;20(5):464-71.

73.Stanford KI, Middelbeek RJ, Townsend KL, Lee MY, Takahashi H, So K, et al. A novel role for subcutaneous adipose tissue in exercise-induced improvements in glucose homeostasis. Diabetes. 2015;64(6):2002-14.

74.Meister BM, Hong SG, Shin J, Rath M, Sayoc J, Park JY. Healthy versus Unhealthy Adipose Tissue Expansion: the Role of Exercise. J Obes Metab Syndr. 2022;31(1):37-50.

75.Wu J, Bostrom P, Sparks LM, Ye L, Choi JH, Giang AH, et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 2012;150(2):366-76.

76.Das E, Moon JH, Lee JH, Thakkar N, Pausova Z, Sung HK. Adipose Tissue and Modulation of Hypertension. Curr Hypertens Rep. 2018;20(11):96.

77.Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, Adipose Tissue and Vascular Dysfunction. Circ Res. 2021;128(7):951-68.

78.Dufek B, Meehan DT, Delimont D, Cheung L, Gratton MA, Phillips G, et al. Endothelin A receptor activation on mesangial cells initiates Alport glomerular disease. Kidney Int. 2016;90(2):300-10.

79.Zhang Y, Ding J. Renal, auricular, and ocular outcomes of Alport syndrome and their current management. Pediatr Nephrol. 2018;33(8):1309-16.

80.Dufek B, Meehan DT, Delimont D, Wilhelm K, Samuelson G, Coenen R, et al. RNA-seq analysis of gene expression profiles in isolated stria vascularis from wild-type and Alport mice reveals key pathways underling Alport strial pathogenesis. PLoS One. 2020;15(8):e0237907.

81.Guseh JS, Churchill TW, Yeri A, Lo C, Brown M, Houstis NE, et al. An expanded repertoire of intensity-dependent exercise-responsive plasma proteins tied to loci of human disease risk. Sci Rep. 2020;10(1):10831.

82.Kirkman DL, Bohmke N, Carbone S, Garten RS, Rodriguez-Miguelez P, Franco RL, et al. Exercise intolerance in kidney diseases: physiological contributors and therapeutic strategies. Am J Physiol Renal Physiol. 2021;320(2):F161-73.

83.Davenport A, Guirguis A, Almond M, Day C, Chilcot J, Da Silva Gane M, et al. Postdialysis recovery time is extended in patients with greater self-reported depression screening questionnaire scores. Hemodial Int. 2018;22(3):369-76.

84.Jhamb M, Weisbord SD, Steel JL, Unruh M. Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors. Am J Kidney Dis. 2008;52(2):353-65.

85.Shim HY, Cho MK. Factors influencing the quality of life of haemodialysis patients according to symptom cluster. J Clin Nurs. 2018;27(9–10):2132-41.

86.You AS, Kalantar SS, Norris KC, Peralta RA, Narasaki Y, Fischman R, et al. Dialysis symptom index burden and symptom clusters in a prospective cohort of dialysis patients. J Nephrol. 2022;35(5):1427-36.

87.Lee KA, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res. 1991;36(3):291-8.

88.Wahida AZ, Rumahorbo H. The effectiveness of intradialytic exercise in ameliorating fatigue symptoms in patients with chronic kidney failure undergoing hemodialysis: A systematic literature review and meta-analysis. J Taibah Univ Med Sci. 2023;18(3):512-25.

89.Gordon PL, Doyle JW, Johansen KL. Postdialysis fatigue is associated with sedentary behavior. Clin Nephrol. 2011;75(5):426-33.

90.Sovatzidis A, Chatzinikolaou A, Fatouros IG, Panagoutsos S, Draganidis D, Nikolaidou E, et al. Intradialytic Cardiovascular Exercise Training Alters Redox Status, Reduces Inflammation and Improves Physical Performance in Patients with Chronic Kidney Disease. Antioxidants. 2020;9(9):868.

91.Brown PDS, Rowed K, Shearer J, MacRae JM, Parker K. Impact of intradialytic exercise intensity on urea clearance in hemodialysis patients. Appl Physiol Nutr Metab. 2018;43(1):101-4.

92.Wilund KR, Viana JL, Perez LM. A Critical Review of Exercise Training in Hemodialysis Patients: Personalized Activity Prescriptions Are Needed. Exerc Sport Sci Rev. 2020;48(1):28-39.

93.Lavin KM, Coen PM, Baptista LC, Bell MB, Drummer D, Harper SA, et al. State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions. Compr Physiol. 2022;12(2):3193-279.

94.Clyne N, Anding-Rost K. Exercise training in chronic kidney disease—effects, expectations and adherence. Clin Kidney J. 2021;14(Supplement_2):ii3-14.

95.Bonomini M, Pieroni L, Di Liberato L, Sirolli V, Urbani A. Examining hemodialyzer membrane performance using proteomic technologies. Ther Clin Risk Manag. 2018;14:1-9.

96.Dubin RF, Rhee EP. Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention. Clin J Am Soc Nephrol. 2020;15(3):404-11.

97.Walkowiak B, Sobol AB, Walczynska M, Kaminska M. Effect of uremia and hemodialysis on proteome profile of blood platelets and plasma. Clin Appl Thromb Hemost. 2013;19(5):541-9.

引用本文

Laurence Poirier,Alexis Marcotte-Chénard,Renaud Tremblay,Lara Deslauriers,Mélanie Godin,Dominique Lévesque,François-Michel Boisvert,Eléonor Riesco*. Acute Effect of Intradialytic Aerobic Exercise on Hemodynamic Response, Dialysis-Related Side Effects and Proteome in Patients with Kidney Failure: A Pilot Study [J]. Advances in Geriatric Medicine and Research. 2024; 6; (4). - .

文献评论

相关学者

相关机构